Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography. - Wikidata - awgldk - TriplyDB

Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

http://www.wikidata.org/entity/Q53065543

about

Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis.18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis.Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis.Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.Current and future treatment of amyloid neuropathies.Nuclear imaging for cardiac amyloidosis.Improving strategies for the diagnosis of cardiac amyloidosis.Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.Recent advances in the noninvasive strategies of cardiac amyloidosis.One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.Role of Imaging in Evaluating Infiltrative Heart Disease.Cardio-oncology: the Nuclear Option.Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.Cardiac Amyloidosis: Diagnosis and Treatment Strategies.A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir.Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.Amyloid PET imaging: applications beyond Alzheimer's disease.Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.Nuclear imaging of cardiac amyloidosis. 'We've only just begun'.Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging.PET-CT evaluation of amyloid systemic involvement with [18F]-florbetaben in patient with proved cardiac amyloidosis: a case report.Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).Imaging cardiac innervation in amyloidosis.Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.Imaging cardiac amyloidosis: an opportunity for nuclear cardiology.Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases.Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.[18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström's Macroglobulinemia.Hybrid positron emission tomography-magnetic resonance of the heart: current state of the art and future applications Emerging Tracers for Nuclear Cardiac PET Imaging Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis

P2860

Q26739729-2E5B98CF-7806-4DC9-90C0-918A4AEB5053 Q28073135-296D06ED-C6E1-4CF3-B8FB-6B140CC2742F Q33793266-061F1728-5F4A-45D3-8D78-2991A1A5D4DF Q35949385-7BBEBBD7-C67A-4F33-8C2C-FEFEEA462479 Q36645348-563A649B-3E3A-4056-933B-04299E8A0BD5 Q36779759-DDE028ED-7DFE-4CBB-9AE8-F000F9995C81 Q36783800-07C91F37-1CAB-4468-ADBA-5585039EF285 Q37703212-2674A632-EF50-4E69-8702-3B76FE34F8FD Q38270497-88A446CD-F378-4AF5-9C35-1F6BA4713BD4 Q38271439-3D645A04-71B3-48BB-A302-26FD39BAD63F Q38547033-60994D1E-F991-4868-9F65-826A40392CE3 Q38663987-C707F9E0-11B7-438B-A6FD-2C8CF39E2021 Q38869625-05FB72F3-0AAB-45AF-B4A8-CF823657F3C7 Q38935425-6A99ABC4-40BA-4F7B-8A6F-3C45AF06AD8D Q39091511-1EE6DE93-3342-4F01-956B-BF8403DEBE52 Q39114674-DF2AA6D4-A4DF-4165-96C1-38AA5E0E6C33 Q39185620-9784753D-4BDC-4B3F-82E8-D11B7DD399E1 Q39309126-BD0C13EA-0DBC-445F-9F13-939B841C54F8 Q39320411-7633A729-7778-4B51-B682-791E805EFDF3 Q40214126-56EDF5DF-EB1E-461C-875C-08332FC21250 Q40316884-1D0C24CC-6733-48FB-8C06-0F74101F8842 Q40737924-A2993243-4B9C-41E8-8957-8C90ACA63462 Q43161462-19501BFD-A520-4819-BC04-933F94114722 Q47637174-CB50E451-14B1-44D1-8D8C-6EECE3006894 Q48040967-C67E7078-E360-424E-810D-5CAC1A25B86D Q48097450-DC886FDE-9BE5-4729-A639-AF2F163319AE Q48252520-04C33480-FDB1-4D4D-9228-86DB4D038058 Q48504995-7648FB25-89CC-49D3-A793-B4E25776E626 Q50192646-88C19362-A7F0-4D94-A5B3-30FF69C8A33E Q51829619-C97B2236-CEA8-485E-A5FF-56BDA889402F Q52982588-308246AD-93C5-4F59-8765-C70717983282 Q53042479-11CB8E6A-0B28-471D-A6A1-5C08B2C34863 Q53206937-BE0CE7F9-200B-4C3A-8763-D3B028625C0E Q55020340-1AA57DA4-DBE6-4705-870B-6B61BDCA71BC Q55041793-E8DB19B5-BB34-4F15-AF6D-3388E02406CF Q55425790-1401125E-1A18-40F2-ADFD-B982DD299508 Q55638333-7E9D8552-C567-4A4F-B464-8FE86DA51352 Q57163501-3BDA92D9-AB57-4C6A-A544-F858E7C1F0C6 Q57173299-BF5744DD-31BC-43B1-97EB-885F007AAFC2 Q57299899-930A538A-E6E7-4818-A89F-B6D332FC8B28

P2860

Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

http://www.wikidata.org/entity/Q53065543

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Imaging cardiac amyloidosis: a ...... positron emission tomography.

@en

Imaging cardiac amyloidosis: a ...... positron emission tomography.

@nl

type

label

Imaging cardiac amyloidosis: a ...... positron emission tomography.

@en

Imaging cardiac amyloidosis: a ...... positron emission tomography.

@nl

prefLabel

Imaging cardiac amyloidosis: a ...... positron emission tomography.

@en

Imaging cardiac amyloidosis: a ...... positron emission tomography.

@nl

P1433

Q53065543-59D8DC97-E51A-4FE8-9B54-861E29FF61BD

P1476

Q53065543-8D413EAE-E8D7-46F1-92B6-B634C3102BF1

P2093

Q53065543-093E7736-0772-4C7B-8F72-6F287507F4A3

Q53065543-1F9682F3-2E99-42A3-9626-17F06E01BBCE

Q53065543-2EF2B8F8-7A8D-4A18-96EA-CBE48511C6FC

Q53065543-360971E9-56A9-45F3-AD80-1F6345E60304

Q53065543-6FABCA0E-18CE-4AD0-8F1A-E8998ACA2C9F

Q53065543-9A68BDA4-A2B0-4918-93F2-50E6AA50726D

Q53065543-BA63C823-6B3A-49E4-8A5E-CE8EF8F903F4

Q53065543-FB47BC57-9874-46EA-96E7-6DFF4E3FB80A

P2860

Q53065543-0EAF9B14-FC71-47B7-8ED6-343EF7FC6F60

Q53065543-1DAA9465-2BC3-4D4A-A9C3-2AF28299D27B

Q53065543-31CD62C0-C046-4E29-92D7-63F0617231DA

Q53065543-48658B9F-C7FA-4907-BBCF-F1C24D173BDF

Q53065543-4BFCBC27-AEFD-46B1-B620-3801142CD5F0

Q53065543-5511CFCB-FB7A-4D00-9BA4-434DC6452D31

Q53065543-65DFCA82-8895-4887-9D7E-3F24D32BDDF8

Q53065543-777931FA-1152-40BA-A85F-EE107146D820

Q53065543-8C713265-A01F-4497-9FFC-D497FFF9BE6F

Q53065543-9D15BA95-1B97-4221-8765-9400D4D657F9

P2888

Q53065543-DE693A68-64BE-4450-8107-9B7ACE4D90B6

P304

Q53065543-0D9B91DB-F84E-4E45-89B6-FD75D2C2AB87

P31

Q53065543-641B1F8C-D5A8-431F-8611-20543D6A8F41

P356

Q53065543-3A6F04C3-7830-4F58-942A-F3F7A9D87399

P433

Q53065543-E72DAEA1-4934-410A-8347-9D72EF331FC1

P478

Q53065543-2E3E0317-1E77-4332-AE90-4DFF8ACCF7BD

P577

Q53065543-538FE7E7-0E50-4558-9BA9-1FAF8381D5CD

P698

Q53065543-635E3D94-3748-4F2B-8281-1AFD5D27B79C

P356

S00259-014-2787-6

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Imaging cardiac amyloidosis: a ...... positron emission tomography.

@en

P2093

Christopher Strader

http://www.w3.org/2001/XMLSchema#string

Divya Vangala

http://www.w3.org/2001/XMLSchema#string

James Semer

http://www.w3.org/2001/XMLSchema#string

John R Bruyere

http://www.w3.org/2001/XMLSchema#string

Marcelo F Di Carli

http://www.w3.org/2001/XMLSchema#string

Rodney H Falk

http://www.w3.org/2001/XMLSchema#string

Sharmila Dorbala

http://www.w3.org/2001/XMLSchema#string

Stephen C Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.

Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Molecular mechanisms of amyloidosis.

Transthyretin (TTR) cardiac amyloidosis.

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

Inhibiting transthyretin amyloid fibril formation via protein stabilization.

Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

P2888

s00259-014-2787-6

P304

1652-1662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-014-2787-6

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24841414

http://www.w3.org/2001/XMLSchema#string